10.02.2013 Views

Presentation Outline ICHP Annual Meeting September 13-15

Presentation Outline ICHP Annual Meeting September 13-15

Presentation Outline ICHP Annual Meeting September 13-15

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

IV Acetaminophen –Average Length of<br />

Stay and Charges<br />

May 2012, ICD‐9 Code 7<strong>15</strong>.36<br />

(When IV APAP was used)<br />

May 2011, ICD‐9 Code<br />

7<strong>15</strong>.36(When IV APAP was NOT<br />

used)<br />

May 2012, ICD‐9 Code<br />

7<strong>15</strong>.35(When IV APAP was used)<br />

May 2011, ICD‐9 Code<br />

7<strong>15</strong>.35(When IV APAP was NOT<br />

used)<br />

May 2012, ICD‐9 Code 654.21<br />

(When IV APAP was used)<br />

May 2011, ICD‐9 Code 654.21<br />

(When IV APAP was NOT used)<br />

Average Length of Stay Average Charges<br />

2.68 days $36,100<br />

2.88 days $35,600<br />

2.56 days $42,600<br />

3 days $42,500<br />

2.56 days $7,700<br />

2.4 days $7,600<br />

Review<br />

• What positives do you see from IV<br />

Acetaminophen use?<br />

• What negatives do you see from IV<br />

Acetaminophen use?<br />

• What additional research data would you like<br />

to see about IV Acetaminophen use?<br />

Assessment Question<br />

Which of the following statements is/are true regarding<br />

the infusion of intravenous acetaminophen?<br />

A. Infusion time is 30 minutes<br />

B. Cmax occurs at 30 minutes<br />

C. Overall AUC is similar to oral administration<br />

D. After penetration of the seal the product should be<br />

used within 12 hour<br />

E. All of the above<br />

IV Acetaminophen – Multiple<br />

Dosing<br />

• <strong>15</strong> patients who<br />

received multiple<br />

doses of IV APAP<br />

(average of 3.23<br />

doses) were randomly<br />

selected and<br />

compared to <strong>15</strong><br />

patients who received<br />

a single dose of IV<br />

APAP.<br />

Total oral<br />

morphine<br />

equivalent<br />

dose<br />

Multiple<br />

doses of IV<br />

APAP<br />

Single dose<br />

of IV APAP<br />

Calculated<br />

p-value<br />

27.93mg 26.47mg 0.8946<br />

Symptoms of 6 patients, 5 patients, 1.0 (Fisher’s<br />

nausea/vomiti receiving g total receiving g total exact test) )<br />

ng 0-24 hours of 10 doses of of 8 doses of<br />

after surgery ondansetron ondansetron<br />

4mg<br />

4mg<br />

Average<br />

lowest oxygen<br />

saturation 0-<br />

24 hours after<br />

surgery<br />

Average<br />

lowest<br />

respiratory<br />

rate 0-24<br />

hours after<br />

surgery<br />

Conclusion<br />

94.2% 94.83%<br />

16.2 16.08<br />

• Place in therapy is undetermined<br />

– Results of our DUE failed to demonstrate that clinical<br />

advantages outweigh the economic burden<br />

• Additional research needed<br />

– Larger sample size<br />

– Time to first physical therapy<br />

– Frequency of nausea and vomiting<br />

• Needs to be proven fiscally responsible<br />

– Anticipated benefits must be observed<br />

Questions<br />

8/29/2012<br />

3

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!